Altor becomes Ferrosan’s new principal shareholder - continued focus on growth
The Nordic investment fund Altor 2003 Fund is acquiring 70 per cent of the shares in Ferrosan, and management is becoming a co-owner of the company. Idosan, the former principal shareholder, will retain 30 per cent of the shares. Novo Nordisk is selling its shares in Ferrosan.Following several years of strong performance, the healthcare and medical devices company Ferrosan is well positioned to further boost its growth. The new principal shareholder, the Altor 2003 Fund, and the company's management see Ferrosan as an attractive platform within the health and dietary supplements sector.